lee011,ribociclib
novartis
['bcsm', 'ribociclib', 'monaleesa2']
 dose reductions do not impact outcome with ribociclib in monaleesa2 2/3 patients on the study actually had dose reductions 83% of pts feel better after reduction #asco22 #bcsm #asco22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.